AU514644B2 - Liposomes - Google Patents

Liposomes

Info

Publication number
AU514644B2
AU514644B2 AU34235/78A AU3423578A AU514644B2 AU 514644 B2 AU514644 B2 AU 514644B2 AU 34235/78 A AU34235/78 A AU 34235/78A AU 3423578 A AU3423578 A AU 3423578A AU 514644 B2 AU514644 B2 AU 514644B2
Authority
AU
Australia
Prior art keywords
liposomes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU34235/78A
Other languages
English (en)
Other versions
AU3423578A (en
Inventor
JR. Fildes F. J. T. and Oliver J. E Evans
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Publication of AU3423578A publication Critical patent/AU3423578A/en
Application granted granted Critical
Publication of AU514644B2 publication Critical patent/AU514644B2/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • A61K9/1277Processes for preparing; Proliposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Peptides Or Proteins (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
AU34235/78A 1977-05-10 1978-03-17 Liposomes Expired AU514644B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB19510/77 1977-05-10
GB19510/77A GB1575343A (en) 1977-05-10 1977-05-10 Method for preparing liposome compositions containing biologically active compounds

Publications (2)

Publication Number Publication Date
AU3423578A AU3423578A (en) 1979-09-20
AU514644B2 true AU514644B2 (en) 1981-02-19

Family

ID=10130587

Family Applications (1)

Application Number Title Priority Date Filing Date
AU34235/78A Expired AU514644B2 (en) 1977-05-10 1978-03-17 Liposomes

Country Status (19)

Country Link
US (2) US4311712A (US06272168-20010807-M00014.png)
JP (1) JPS53142514A (US06272168-20010807-M00014.png)
AU (1) AU514644B2 (US06272168-20010807-M00014.png)
BE (1) BE866697A (US06272168-20010807-M00014.png)
CA (1) CA1114758A (US06272168-20010807-M00014.png)
CH (2) CH650944A5 (US06272168-20010807-M00014.png)
DE (1) DE2818655C2 (US06272168-20010807-M00014.png)
DK (2) DK156765C (US06272168-20010807-M00014.png)
FI (1) FI63856C (US06272168-20010807-M00014.png)
FR (1) FR2390159A1 (US06272168-20010807-M00014.png)
GB (1) GB1575343A (US06272168-20010807-M00014.png)
IE (1) IE46571B1 (US06272168-20010807-M00014.png)
IL (2) IL54270A (US06272168-20010807-M00014.png)
IT (1) IT1094811B (US06272168-20010807-M00014.png)
NL (1) NL7805005A (US06272168-20010807-M00014.png)
NO (3) NO150184C (US06272168-20010807-M00014.png)
NZ (1) NZ186696A (US06272168-20010807-M00014.png)
SE (3) SE440725B (US06272168-20010807-M00014.png)
ZA (1) ZA781416B (US06272168-20010807-M00014.png)

Families Citing this family (122)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH621479A5 (US06272168-20010807-M00014.png) * 1977-08-05 1981-02-13 Battelle Memorial Institute
IT1110989B (it) * 1979-01-19 1986-01-13 Erba Farmitalia Forme farmaceutiche costitutite da liposomi e procedimenti relativi
FR2416008A1 (fr) * 1978-02-02 1979-08-31 Oreal Lyophilisats de liposomes
IT1111367B (it) * 1978-11-17 1986-01-13 Serono Ist Farm Processo per la preparazione estemporanea di liposomi e liposomi cosi' ottenuti
JPS55118415A (en) * 1979-02-28 1980-09-11 Pii Papahadojiyopo Dometoriosu Method of encapsulating biologically active substance in lipoid cell
DE2914789A1 (de) * 1979-04-11 1980-10-16 Nattermann A & Cie Injizierbare arzneimittel mit entzuendungshemmender wirkung
DE2914788A1 (de) * 1979-04-11 1980-10-16 Nattermann A & Cie Parenteral applizierbare, stabile arzneimittelloesungen mit entzuendungshemmender wirkung
JPS55153713A (en) * 1979-05-02 1980-11-29 Kureha Chem Ind Co Ltd Pharmaceutical preparation of ribosome containing active substance
CA1173360A (en) * 1979-06-22 1984-08-28 Jurg Schrank Pharmaceutical preparations
US4310505A (en) * 1979-11-08 1982-01-12 California Institute Of Technology Lipid vesicles bearing carbohydrate surfaces as lymphatic directed vehicles for therapeutic and diagnostic substances
HU184141B (en) * 1979-12-27 1984-07-30 Human Oltoanyagtermelo Adjuvant particles compositions containing said particles and biologically active substances adsorbed thereon and a process for the preparation thereof
JPS5775916A (en) * 1980-10-29 1982-05-12 Nippon Chemiphar Co Ltd Coenzyme q pharmaceutical and its preparation
JPS57146710A (en) * 1981-03-07 1982-09-10 Kunio Yagi Blood brain-barrier permeating ribosome-like microcapsule
US4397846A (en) * 1981-05-15 1983-08-09 Murray Weiner Storage-stable lipid vesicles and method of preparation
JPS58128318A (ja) * 1982-01-22 1983-07-30 フアイソンズ・ピ−エルシ− 薬学的組成物
JPS58222014A (ja) * 1982-06-18 1983-12-23 Taisho Pharmaceut Co Ltd プロスタグランジンe↓1脂肪乳剤
US4588578A (en) * 1983-08-08 1986-05-13 The Liposome Company, Inc. Lipid vesicles prepared in a monophase
GB8322178D0 (en) * 1983-08-17 1983-09-21 Sterwin Ag Preparing aerosol compositions
US4744989A (en) * 1984-02-08 1988-05-17 E. R. Squibb & Sons, Inc. Method of preparing liposomes and products produced thereby
US5141674A (en) * 1984-03-08 1992-08-25 Phares Pharmaceutical Research N.V. Methods of preparing pro-liposome dispersions and aerosols
JPS60208910A (ja) * 1984-03-31 1985-10-21 Green Cross Corp:The 水難溶性薬物・リン脂質複合体の製造方法
SE8403905D0 (sv) * 1984-07-30 1984-07-30 Draco Ab Liposomes and steroid esters
US5736155A (en) * 1984-08-08 1998-04-07 The Liposome Company, Inc. Encapsulation of antineoplastic agents in liposomes
US5077056A (en) * 1984-08-08 1991-12-31 The Liposome Company, Inc. Encapsulation of antineoplastic agents in liposomes
US4880635B1 (en) * 1984-08-08 1996-07-02 Liposome Company Dehydrated liposomes
DE3582905D1 (de) * 1984-08-10 1991-06-27 Syntex Inc Stabile liposome mit wasserloeslichen arzneimitteln.
JPS6150912A (ja) * 1984-08-16 1986-03-13 Shionogi & Co Ltd リポソ−ム製剤の製造法
JPS61100518A (ja) * 1984-10-22 1986-05-19 Ono Pharmaceut Co Ltd ジミリストイルホスフアチジルコリンを主成分とする凍結乾燥されたリポゾ−ム製剤
US4857319A (en) * 1985-01-11 1989-08-15 The Regents Of The University Of California Method for preserving liposomes
US4830858A (en) * 1985-02-11 1989-05-16 E. R. Squibb & Sons, Inc. Spray-drying method for preparing liposomes and products produced thereby
US5409704A (en) * 1985-06-26 1995-04-25 The Liposome Company, Inc. Liposomes comprising aminoglycoside phosphates and methods of production and use
FR2591105B1 (fr) * 1985-12-11 1989-03-24 Moet Hennessy Rech Composition pharmaceutique, notamment dermatologique, ou cosmetique, a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un retinoide ou un analogue structural dudit retinoide tel qu'un carotenoide.
US5068198A (en) * 1986-03-26 1991-11-26 Syntex (U.S.A.) Inc. Liquid single reagent for assays involving confining gels
SE8601457D0 (sv) * 1986-04-01 1986-04-01 Draco Ab Compositions of liposomes and b?712-receptor active substances for inhalation
FR2597345B1 (fr) * 1986-04-22 1990-08-03 Oreal Composition cosmetique ou pharmaceutique a base d'une dispersion aqueuse de spherules lipidiques.
SE8603812D0 (sv) * 1986-09-12 1986-09-12 Draco Ab Administration of liposomes to mammals
US4891324A (en) * 1987-01-07 1990-01-02 Syntex (U.S.A.) Inc. Particle with luminescer for assays
US5089181A (en) * 1987-02-24 1992-02-18 Vestar, Inc. Method of dehydrating vesicle preparations for long term storage
US5811119A (en) * 1987-05-19 1998-09-22 Board Of Regents, The University Of Texas Formulation and use of carotenoids in treatment of cancer
US5262168A (en) * 1987-05-22 1993-11-16 The Liposome Company, Inc. Prostaglandin-lipid formulations
US5082664A (en) * 1987-05-22 1992-01-21 The Liposome Company, Inc. Prostaglandin-lipid formulations
US5925375A (en) * 1987-05-22 1999-07-20 The Liposome Company, Inc. Therapeutic use of multilamellar liposomal prostaglandin formulations
US4963362A (en) * 1987-08-07 1990-10-16 Regents Of The University Of Minnesota Freeze-dried liposome mixture containing cyclosporin
US4950432A (en) * 1987-10-16 1990-08-21 Board Of Regents, The University Of Texas System Polyene microlide pre-liposomal powders
US5178875A (en) * 1991-01-14 1993-01-12 The Board Of Regents, The University Of Texas System Liposomal-polyene preliposomal powder and method for its preparation
US5830498A (en) * 1987-10-16 1998-11-03 Board Of Regents, The University Of Texas System Liposomal-polyene preliposomal powder and method for its preparation
US4981690A (en) * 1987-10-27 1991-01-01 Board Of Regents, The University Of Texas System Liposome-incorporated mepartricin
JPH0610131B2 (ja) * 1987-10-30 1994-02-09 テルモ株式会社 リポソームの製法
WO1989006977A1 (en) * 1988-02-04 1989-08-10 Board Of Regents, The University Of Texas System Formulation and use of retinoids in treatment of cancer and other diseases
US5096629A (en) * 1988-08-29 1992-03-17 501 Nippon Fine Chemical Co., Ltd. Method for preparing lipid powder for use in preparing liposomes and method for preparing liposomes
ATE147633T1 (de) * 1988-10-27 1997-02-15 Univ Minnesota Immunhilfsmittel aus liposome enthaltend lymphokin il -2
US5174988A (en) * 1989-07-27 1992-12-29 Scientific Development & Research, Inc. Phospholipid delivery system
US7083778B2 (en) * 1991-05-03 2006-08-01 Bracco International B.V. Ultrasound contrast agents and methods of making and using them
US5578292A (en) 1991-11-20 1996-11-26 Bracco International B.V. Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof
US6989141B2 (en) * 1990-05-18 2006-01-24 Bracco International B.V. Ultrasound contrast agents and methods of making and using them
US5445813A (en) * 1992-11-02 1995-08-29 Bracco International B.V. Stable microbubble suspensions as enhancement agents for ultrasound echography
US6613306B1 (en) 1990-04-02 2003-09-02 Bracco International B.V. Ultrasound contrast agents and methods of making and using them
USRE39146E1 (en) 1990-04-02 2006-06-27 Bracco International B.V. Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof
US20040208826A1 (en) * 1990-04-02 2004-10-21 Bracco International B.V. Ultrasound contrast agents and methods of making and using them
US20010024638A1 (en) * 1992-11-02 2001-09-27 Michel Schneider Stable microbubble suspensions as enhancement agents for ultrasound echography and dry formulations thereof
IN172208B (US06272168-20010807-M00014.png) * 1990-04-02 1993-05-01 Sint Sa
US20030194376A1 (en) * 1990-05-18 2003-10-16 Bracco International B.V. Ultrasound contrast agents and methods of making and using them
AU636481B2 (en) * 1990-05-18 1993-04-29 Bracco International B.V. Polymeric gas or air filled microballoons usable as suspensions in liquid carriers for ultrasonic echography
EP0555229B1 (en) * 1990-07-31 1996-06-05 The Liposome Company, Inc. Accumulation of amino acids and peptides into liposomes
US6251581B1 (en) 1991-05-22 2001-06-26 Dade Behring Marburg Gmbh Assay method utilizing induced luminescence
US5340716A (en) * 1991-06-20 1994-08-23 Snytex (U.S.A.) Inc. Assay method utilizing photoactivated chemiluminescent label
US5885260A (en) * 1991-05-30 1999-03-23 Mehl, Sr.; Thomas L. Freeze-dried liposome delivery system for application of skin treatment agents
CA2110490C (en) * 1991-06-18 2008-07-29 Evan C. Unger Drug delivery systems comprising gas-filled liposomes at least 90% devoid of liquid in their interior
FR2681781A1 (fr) * 1991-09-30 1993-04-02 Oreal Composition cosmetique anhydre de maquillage comprenant une phase grasse et procede de traitement cosmetique utilisant cette composition.
ATE171071T1 (de) * 1991-12-31 1998-10-15 Zymogenetics Inc Verfahren und zusammensetzungen zur verminderung von blutverlust
IL104084A (en) * 1992-01-24 1996-09-12 Bracco Int Bv Sustainable aqueous suspensions of pressure-resistant and gas-filled blisters, their preparation, and contrast agents containing them
US5736141A (en) * 1992-06-05 1998-04-07 Dalhousie University Method to prevent fertilization in mammals by administering a single dose of zona pellucida derived antigens, liposome and Freund's adjuvant
USRE37224E1 (en) * 1992-06-05 2001-06-12 Dalhousie University Method to prevent fertilization in mammals by administering a single dose of zona pellucida derived antigens, liposome and adjuvant
JP3464798B2 (ja) * 1992-07-31 2003-11-10 デイド・ベーリング・マルブルク・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング 光活性化化学発光基質
DE4309579C3 (de) * 1993-03-24 2000-01-27 Sanol Arznei Schwarz Gmbh Pharmazeutische Zusammensetzung in Form einer Packung
ATE164515T1 (de) * 1993-11-05 1998-04-15 Amgen Inc Herstellung von liposomen und verfahren zur substanzverkapselung
CA2154867C (en) * 1993-12-15 2007-05-29 Feng Yan Gas mixtures useful as ultrasound contrast media
IT1269569B (it) * 1994-04-22 1997-04-08 Ugo Citernesi Procedimento per la preparazione di complessi fra fosfolipidi e principi attivi utili per la produzione di liposomi e principi attivi e liposomi ottenuti con il procedimento
US6156337A (en) * 1994-07-08 2000-12-05 Opperbas Holding B.V. Method for high loading of vesicles with biopolymeric substances
IL115099A (en) * 1994-10-14 1999-04-11 Upjohn Co Lyophilizate of phospholipid complex of water insoluble camptothecins
US5990077A (en) 1995-04-14 1999-11-23 1149336 Ontario Inc. Glucagon-like peptide-2 and its therapeutic use
US5834428A (en) * 1995-04-14 1998-11-10 1149336 Ontario Inc. Glucagon-like peptide-2 and its therapeutic use
US6184201B1 (en) 1995-04-14 2001-02-06 Nps Allelix Corp. Intestinotrophic glucagon-like peptide-2 analogs
US5902604A (en) 1995-06-06 1999-05-11 Board Of Regents, The University Of Texas System Submicron liposome suspensions obtained from preliposome lyophilizates
PT906338E (pt) 1996-04-12 2003-03-31 Ontario Inc 1149336 Analogos do peptido 2 do tipo glucagon
US6111081A (en) * 1996-05-31 2000-08-29 Baylor College Of Medicine Lactoferrin variants and uses thereof
NZ335592A (en) * 1996-10-25 2000-10-27 Monsanto Co Composition containing an exogenous chemical and a quaternary ammonium excipient for treating plant
HUP9903889A3 (en) * 1996-10-25 2004-07-28 Monsanto Technology Llc St Louis Composition and method for treating plants with exogenous chemicals
US6037125A (en) * 1996-11-05 2000-03-14 Lexicon Genetics Incorporated Disruption of the mammalian RAD51 protein and disruption of proteins that associate with mammalian RAD51 for hindering cell proliferation and/or viability of proliferating cells
CA2236519C (en) 1997-05-02 2011-09-13 1149336 Ontario Inc. Methods of enhancing functioning of the large intestine
DE60136490D1 (de) * 2000-11-09 2008-12-18 Neopharm Inc Sn-38-lipidkomplexe und verfahren zu ihrer verwendung
AU3169702A (en) * 2000-12-07 2002-06-18 Yamanouchi Europ Bv Composition for treatment of inflammatory disorders
WO2003030864A1 (en) * 2001-05-29 2003-04-17 Neopharm, Inc. Liposomal formulation of irinotecan
US6939564B2 (en) * 2001-06-08 2005-09-06 Labopharm, Inc. Water-soluble stabilized self-assembled polyelectrolytes
US6780324B2 (en) * 2002-03-18 2004-08-24 Labopharm, Inc. Preparation of sterile stabilized nanodispersions
US20040082521A1 (en) * 2002-03-29 2004-04-29 Azaya Therapeutics Inc. Novel formulations of digitalis glycosides for treating cell-proliferative and other diseases
US20060093661A1 (en) * 2002-05-07 2006-05-04 Kapac, Llc Methods and formulations for enhancing the absorption and gastro-intestinal bioavailability of hydrophobic drugs
US20030212046A1 (en) * 2002-05-07 2003-11-13 Kapac, Llc Methods and formulations for enhancing the absorption and gastro-intestinal bioavailability of hydrophobic drugs
US20050152962A1 (en) * 2002-06-12 2005-07-14 Metselaar Josbert M. Composition for treatment of inflammatory disorders
AU2003296897A1 (en) * 2002-08-20 2004-05-04 Neopharm, Inc. Pharmaceutical formulations of camptothecine derivatives
US20060030578A1 (en) * 2002-08-20 2006-02-09 Neopharm, Inc. Pharmaceutically active lipid based formulation of irinotecan
EP1393720A1 (en) * 2002-08-27 2004-03-03 Universiteit Utrecht Vesicle-encapsulated corticosteroids for treatment of cancer
KR100651728B1 (ko) * 2004-11-10 2006-12-06 한국전자통신연구원 정착기를 갖는 전자 소자용 화합물 및 이를 포함하는 전자소자와 이들의 제조 방법
US20060198891A1 (en) * 2004-11-29 2006-09-07 Francois Ravenelle Solid formulations of liquid biologically active agents
WO2006071659A1 (en) * 2004-12-29 2006-07-06 Trustees Of Boston University Delivery of h2 antagonists
EP1868574B1 (de) 2005-04-13 2010-01-06 Abbott GmbH & Co. KG Verfahren zur schonenden herstellung hochfeiner partikelsuspensionen und hochfeiner partikel sowie deren verwendung
DE102005017777A1 (de) * 2005-04-13 2006-10-19 Pharmasol Gmbh Verfahren zur schonenden Herstellung von hochfeinen Partikelsuspensionen
KR20090080046A (ko) * 2006-09-22 2009-07-23 라보팜 인코포레이트 pH 표적화된 약물 운반용 조성물 및 방법
US7960336B2 (en) 2007-08-03 2011-06-14 Pharmain Corporation Composition for long-acting peptide analogs
EP2555791B1 (en) 2010-04-09 2017-11-01 Sinai Health System Methods for treating disorders of the gastrointestinal tract using a glp-1 agonist
WO2012094033A1 (en) 2011-01-05 2012-07-12 Livon Laboratories Methods of making liposomes, liposome compositions made by the methods, and methods of using the same
US20160194365A1 (en) 2013-07-08 2016-07-07 The University Of Utah Research Foundation Methods for treatment of and prophylaxis against inflammatory disorders
US10772926B2 (en) 2016-12-16 2020-09-15 Nutragen Health Innovations, Inc. Natural drugs for the treatment of inflammation and melanoma
WO2018204918A1 (en) 2017-05-05 2018-11-08 Ardelyx, Inc. Treatment of hepatic disorders
CA3093723A1 (en) 2018-03-21 2019-09-26 Colorado State University Research Foundation Cancer vaccine compositions and methods of use thereof
RU2740553C2 (ru) * 2019-01-30 2021-01-15 Анастасия Андреевна Карбаинова Способ получения липосомальной формы бетулина, обладающей гепатопротекторной активностью
LT6699B (lt) 2019-07-15 2020-02-10 UAB "Valentis" Proliposomų gamybos būdas, naudojant ne daugiau kaip 5 % etanolio, ir jų panaudojimas lipofilinių medžiagų kapsuliavimui
WO2021178877A1 (en) 2020-03-06 2021-09-10 The Colorado State University Research Foundation Production of vaccines comprising inactivated sars-cov-2 viral particles
WO2022023450A1 (en) 2020-07-28 2022-02-03 Jazz Pharmaceuticals Ireland Limited Chiral synthesis of fused bicyclic raf inhibitors
MX2023001275A (es) 2020-07-28 2023-04-24 Jazz Pharmaceuticals Ireland Ltd Inhibidores de raf biciclicos fusionados y metodos para su uso.
EP4312536A1 (en) 2021-04-01 2024-02-07 Vestaron Corporation Liposome formulations for pesticide delivery and methods for producing and using the same
AU2022398450A1 (en) 2021-11-23 2024-06-06 Sail Biomedicines, Inc. A bacteria-derived lipid composition and use thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3549382A (en) * 1968-05-15 1970-12-22 Francis Frederick Hansen Method of preparing powdered monoglyceride material
FR2081586A2 (en) * 1970-01-24 1971-12-10 Orsymonde Dehydrated pharmaceutical comps by - lyophilisation
US3597455A (en) * 1969-05-29 1971-08-03 Squibb & Sons Inc Process for manufacture of sterile lecithin
CH558659A (fr) * 1969-11-26 1975-02-14 Orsymonde Procede pour la preparation d'une composition lyophilisee a usage hygienique.
FR2101044A2 (en) * 1969-11-26 1972-03-31 Orsymonde Freeze-dried oil - in - water emulsions - for treatment of mouth , teeth, hair and scalp
DE2249552A1 (de) * 1971-10-12 1973-05-30 Inchema S A Verfahren zur inkapsulation von insbesondere wasserloeslichen verbindungen
BE795516A (fr) * 1972-02-17 1973-08-16 Ciba Geigy Preparations de peptides huileuses et injectables et procede pour leur preparation
CH588887A5 (US06272168-20010807-M00014.png) * 1974-07-19 1977-06-15 Battelle Memorial Institute
US3957971A (en) * 1974-07-29 1976-05-18 Lever Brothers Company Moisturizing units and moisturizing compositions containing the same
JPS5126213A (ja) * 1974-08-21 1976-03-04 Tanabe Seiyaku Co Johoseibiryushiseizaino seiho
JPS5186117A (en) * 1975-01-27 1976-07-28 Tanabe Seiyaku Co Johoseibiryushiseizainoseiho
FR2315991A1 (fr) * 1975-06-30 1977-01-28 Oreal Procede de fabrication de dispersions aqueuses de spherules lipidiques et nouvelles compositions correspondantes
DK141082B (da) * 1976-01-13 1980-01-14 Battelle Memorial Institute Fremgangsmåde til fremstilling af liposomer indeholdende biologisk aktivt stof dispergeret i et vandigt medium.

Also Published As

Publication number Publication date
IL61475A0 (en) 1980-12-31
NO153121B (no) 1985-10-14
NO153121C (no) 1986-01-22
NO780838L (no) 1978-11-13
ZA781416B (en) 1979-03-28
AU3423578A (en) 1979-09-20
DK122388D0 (da) 1988-03-07
US4311712A (en) 1982-01-19
DE2818655A1 (de) 1978-11-23
IT7823207A0 (it) 1978-05-10
CA1114758A (en) 1981-12-22
NO834219L (no) 1978-11-13
NZ186696A (en) 1980-10-08
FR2390159A1 (fr) 1978-12-08
IL54270A (en) 1981-06-29
DK206578A (da) 1978-11-11
DK156765C (da) 1990-02-19
DE2818655C2 (de) 1987-05-14
SE454049B (sv) 1988-03-28
SE8201350L (sv) 1982-03-04
IL54270A0 (en) 1978-06-15
FR2390159B1 (US06272168-20010807-M00014.png) 1983-01-14
SE7805276L (sv) 1978-11-11
GB1575343A (en) 1980-09-17
US4370349A (en) 1983-01-25
FI63856C (fi) 1983-09-12
CH650944A5 (de) 1985-08-30
DK156765B (da) 1989-10-02
JPS53142514A (en) 1978-12-12
NL7805005A (nl) 1978-11-14
BE866697A (fr) 1978-11-03
DK122388A (da) 1988-03-07
SE440725B (sv) 1985-08-19
FI781012A (fi) 1978-11-11
IE780464L (en) 1978-11-10
NO150184B (no) 1984-05-28
NO840064L (no) 1978-11-13
CH652615A5 (de) 1985-11-29
JPS6252724B2 (US06272168-20010807-M00014.png) 1987-11-06
IT1094811B (it) 1985-08-10
NO150184C (no) 1984-09-05
SE8201351L (sv) 1982-03-04
IE46571B1 (en) 1983-07-27
FI63856B (fi) 1983-05-31
SE453962B (sv) 1988-03-21

Similar Documents

Publication Publication Date Title
AU514644B2 (en) Liposomes
AU520916B2 (en) Preparing liposomes
AU3409978A (en) 4-acylaminophenyl-ethanolamines
AU3506678A (en) Polyetheramide-acids
AU3782678A (en) 1-acyl-2-cyanoaziridines
AU3662478A (en) Pyridobenzodiazepines
AU3069177A (en) Inkduct
AU3780378A (en) Circuit-tester
AU3347978A (en) Phenyl-benzimidazoyl-furanes
AU3662278A (en) Pyridobenzoiazepines
AU3216278A (en) Phenylcarbamoyl-pyrazolines
AU3216478A (en) Phenylcarbamoyl-2-pyrazolines
AU3732478A (en) a-ETHYNYL TRYTOPHANES
AU524481B2 (en) Rifanycins
AU3239278A (en) Dithienylalkylamines
AU3764478A (en) Benzylpyrimidines
AU3492478A (en) 4-alkylthio-2-trifluoromethylalkanesulfonides
AU3401278A (en) Sipper-seal
AU3307178A (en) Chloroacetanylides
AU3732678A (en) Alpha-vinyl tryptophanes
AU3418778A (en) Hydroxylated-1d-2d-methylene-steroids
AU3706678A (en) Pyridazinylhydrazines
AU3246878A (en) Arylenedioxy-bis-diketones
AU3790378A (en) Amidino-benzylpyrimidines
AU3670578A (en) 4-phenyl-8-amino-tetrahydroisoquinolines